Executive Console

Verifying your session…

Executive Console

Strategic Intelligence Queue

AI COUNCIL

W

O

R

C

P

T

HIPAA · 42 CFR Part 2 VETO GATE: CLEAR ● PHOENIX ACTIVE

Phoenix: Active

SOC 2: Compliant

Next Briefing 8:00am

Consult The Council

Domain: Auto-detected

Impact: System-assigned

Urgency: Standard

All requests are evaluated for safety, compliance, and execution capacity.

AI Chief of Staff Ready

Pick a preset or ask a question to get a bulleted action list.

Forecast — Decisions Required (2)

ACO Partnership Contract

Horizon Health Partners • $4.2M annual value

Mon

Dr. Williams strategic analysis: 23% margin improvement projected, aligns with value-based care initiative

Board vote scheduled Monday. Contract includes shared savings model with 45% upside on quality metrics. CFO recommends approval with amended termination clause.

State DHHS Audit Response

Compliance Review • 42 CFR Part 2

Dec 20

Dr. Chen compliance assessment: 3 minor findings, all corrective actions documented

Annual state audit findings require executive sign-off. No material issues. Response letter drafted by compliance team.

Forecast — Strategic Items (3)

Q4 Board Presentation

Strategic Review • January 8, 2026

25 days

Annual strategic review presentation. Key topics: AI platform performance, pilot expansion plan, 2026 growth targets.

Pilot Site Expansion

3 New Facilities Proposed • Q1 2026

Planning

Phoenix Recovery (AZ), Harbor Behavioral (CA), Summit Treatment (CO) have completed technical readiness. Combined 450 new beds.

Growth Engine (…)

Pipeline —

Loading pipeline…

Outreach —

Loading outreach…

Marketing —

Loading marketing…

Grants —

Loading grants…

Activations —

Loading activations…

Live Grants (0)

Connecting to grant pipeline...

Completed This Week (2)

BlueCross Contract Signed

In-network status • Effective Jan 1

Signed

CMO Search Finalized

Dr. Chen starts Feb 1

Complete

Financial Alerts (1)

Days in A/R Exceeds Target

48 days • Target: 35 days • $890K impact

Review

Dr. Taylor analytics: Denial rate up 12% — primarily prior auth issues with Aetna plans

Accounts receivable aging has deteriorated 37% since October. Root cause: increased denial rate from commercial payers. Revenue cycle team recommends dedicated appeals resource.

Financial Tasks (3)

Q4 Close — Accruals Review

Year-end adjustments • $2.1M accrued expenses

Dec 31

Final review of year-end accruals. Key items: deferred revenue recognition, bonus accruals, and vendor true-ups.

2026 Operating Budget

Final Board Approval • $18.4M total

Jan 8

Operating budget finalized. 12% revenue growth projected. Key investments: AI platform expansion, 3 new pilot sites, staffing increases.

CMS Reimbursement Rate Analysis

2026 OPPS Final Rule • -1.3% impact projected

Planning

New Medicare rates effective Jan 1. Behavioral health carve-in changes require payer contract renegotiations. Net impact -$340K annually.

On Track (2)

Operating Margin

8.2% YTD • Target: 7%

Exceeds

Cash Position

$4.8M • 5.2 months runway

Healthy

Nursing Attention Required (2)

Night Shift Staffing Ratio

1:8 ratio • Target: 1:6 • Unit 2B

Tonight

Dr. Olivia behavioral alert: Higher acuity patients on 2B — 3 active crisis protocols

Two call-outs for tonight's shift. Float pool contacted. PRN nurse confirmed for 11p-7a. Charge nurse aware of coverage gap 7p-11p.

Fall Risk — Unit 3A

2 incidents this week • Both during shift change

Review

Two patient falls during 7am shift change. No injuries reported. Root cause: inadequate handoff during high-risk patient transfer.

Care Coordination (2)

Discharge Planning Backlog

14 patients • Avg 2.3 days past target

Ongoing

Delayed discharges primarily due to outpatient follow-up scheduling. Case management working with community partners to expedite.

MAT Training Compliance

87% complete • 8 nurses due for recert

Dec 31

Annual MAT certification renewal. Online modules available. 8 nurses need to complete before year-end for compliance.

Meeting Standards (2)

Patient Satisfaction — Nursing

4.6/5.0 • Top quartile

Excellent

Medication Error Rate

0.02% • Below benchmark

Target Met

Clinical Quality Alerts (1)

30-Day Readmission Rate Elevated

18% • Target: 12% • 14 patients

Analyze

Dr. Olivia pattern analysis: 71% readmits had <3 days between discharge and first crisis indicator

Readmission spike correlates with shortened length of stay initiative. AI analysis suggests discharge criteria may be premature for high-acuity SUD patients.

Medical Staff Items (3)

Peer Review — 3 Cases Pending

Quality Committee • Due this month

Dec 20

Three cases flagged for peer review: 2 medication dosing questions, 1 treatment plan adequacy. Committee meeting scheduled Friday.

MAT Protocol Update

Buprenorphine guidelines • ASAM 2024 standards

Jan 15

Update clinical protocols to align with new ASAM guidelines. Key changes: flexible dosing, telehealth prescribing, take-home allowances.

Credentialing Renewals

2 physicians due • Q1 2026

Feb 1

Dr. Brennan and Dr. Hayes credentials expire Feb 1. Applications submitted, pending verification. No concerns anticipated.

Quality Targets Met (2)

Treatment Completion Rate

76% • SAMHSA benchmark: 65%

Exceeds

Crisis Prediction Accuracy

94% sensitivity • The Council validated

Validated

Operations Watch (2)

Bed Capacity at 92%

46/50 beds occupied • 4 pending admits

Monitor

Dr. Williams forecast: 3 discharges expected tomorrow, waitlist has 7 patients

Near capacity with holiday admissions surge. Discharge planning prioritized. Overflow protocols on standby if occupancy hits 96%.

Intake Evaluation Backlog

14 pending evals • Avg wait: 2.3 days

48h

Intake bottleneck due to clinical staff PTO. Telehealth evaluations offered to reduce wait times. 6 scheduled for tomorrow.

Operational Tasks (2)

Wearable Vendor Contract Renewal

BioSense Inc • $340K annual • Expires Jan 31

Jan 15

Contract renewal with 8% price increase. Negotiating volume discount based on pilot expansion. Alternative vendor quotes obtained.

CARF Survey Preparation

Accreditation survey • January 15-17

32 days

Three-year accreditation renewal. Mock survey completed with 2 minor findings (both corrected). Staff preparation sessions scheduled next week.

On Target (2)

Average Length of Stay

28 days • Target: 30 days

Efficient

Facility Utilization

89% avg • Optimal range

Balanced

DEMO DATA